Related Experiment Video
Updated: Apr 18, 2026
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.3K
Summary
This study shows CH50 can measure complement blockade effectiveness in paroxysmal nocturnal hemoglobinuria (PNH) patients treated with eculizumab. CH50 is a promising biomarker for monitoring PNH therapy.
Area of Science:
- Hematology
- Immunology
- Pharmacology
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder characterized by complement-mediated hemolysis.
- Eculizumab is a C5 inhibitor used to treat PNH, but monitoring its therapeutic effect requires further investigation.
Purpose of the Study:
- To systematically evaluate the pharmacodynamic effects of eculizumab in PNH patients.
- To assess the utility of CH50 as a biomarker for complement blockade in PNH.
Main Methods:
- Ex vivo measurement of complement activity in PNH patients undergoing eculizumab treatment.
- Pharmacodynamic (PD) analysis of complement inhibition.
Main Results:
- Eculizumab treatment leads to a measurable blockade of complement activity.
- CH50 levels demonstrated a strong correlation with the degree of complement inhibition.
Conclusions:
- CH50 serves as a reliable and promising biomarker for assessing therapeutic complement blockade in PNH patients on eculizumab.
- This study provides the first systematic pharmacodynamic data on eculizumab in PNH, supporting CH50's role in patient management.
Related Concept Videos
01:27Complement System
13.2K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
13.2K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.3K
01:19Depolarizing Blockers: Pharmocokinetics
744
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
744
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
965
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
965
01:26Antibody Actions
4.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
4.1K
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.9K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.9K